Low doses of cisplatin or gemcitabine plus Photofrin/photodynamic therapy: Disjointed cell cycle phase-related activity accounts for synergistic outcome in metastatic non-small cell lung cancer cells (H1299).
about
Chemophototherapy: An Emerging Treatment Option for Solid TumorsWee1 inhibition by MK-1775 leads to tumor inhibition and enhances efficacy of gemcitabine in human sarcomasPhotodynamic therapy and cancer: a brief sightseeing tour.Targeted inhibition of p38MAPK-enhanced autophagy in SW620 cells resistant to photodynamic therapy-induced apoptosis.Photodynamic therapy of human lung cancer xenografts in mice.Mitochondrial Malfunctioning, Proteasome Arrest and Apoptosis in Cancer Cells by Focused Intracellular Generation of Oxygen Radicals.Combination of Near Infrared Light-Activated Photodynamic Therapy Mediated by Indocyanine Green with Etoposide to Treat Non-Small-Cell Lung CancerEnhancing photodynamyc therapy efficacy by combination therapy: dated, current and oncoming strategiesEffective method for the isolation and proliferation of primary lung cancer cells from patient lung tissues.Nrf2 inhibition sensitizes cholangiocarcinoma cells to cytotoxic and antiproliferative activities of chemotherapeutic agents.(Metallo)porphyrins as potent phototoxic anti-cancer agents after irradiation with red light.Energy metabolism targeted drugs synergize with photodynamic therapy to potentiate breast cancer cell death.Cells derived from normal or cancer breast tissue exhibit different growth properties when deprived of arginine.Targets and mechanisms of photodynamic therapy in lung cancer cells: a brief overview.Plasmonic Nanoparticle-based Hybrid Photosensitizers with Broadened Excitation Profile for Photodynamic Therapy of Cancer Cells.Photodynamic Synergistic Effect of Pheophorbide a and Doxorubicin in Combined Treatment against Tumoral CellsSonodynamic and photodynamic therapy in advanced breast carcinoma: a report of 3 cases.Allyl-isatin suppresses cell viability, induces cell cycle arrest, and promotes cell apoptosis in hepatocellular carcinoma HepG2 cells.Antibody-assisted target identification reveals afatinib, an EGFR covalent inhibitor, down-regulating ribonucleotide reductase.
P2860
Q28468315-B2087BDE-747E-4C8B-A26C-1B9C4B04A0C7Q28487835-E6CC024D-90A9-40BC-B582-F861FE589AA9Q33276646-D9C538C1-1C13-4A4F-B349-14B9E7799B4BQ35740530-288F161F-DEC5-49B3-A1B6-4233E7B43AABQ35818104-E789B35A-BD39-4F83-B6CF-B9E8AD95ED54Q36183959-788922FD-7720-4817-AF89-6C2891895832Q36394224-03DC1FD4-961A-4B8D-8C7A-80286D3CA26EQ38161363-6A919916-F3CB-4D5A-A319-BD3F93391012Q38451291-648EE489-078A-4B0F-AF5E-8049E8EF14CFQ38783129-D85E6539-FFF6-4312-9EA9-A776D347B36EQ38938042-92565E76-AE08-4E33-AB23-AF5515CE7DC8Q38943330-CD6B7745-7C8F-46EC-9C49-87D4BB0A5E42Q39425455-B58BBCC1-8E16-4B91-AEE1-F5B236D28B0FQ39799148-5B06CD6C-EC75-48D8-883C-FD983AC559ACQ41388983-A941DBF1-09C2-4A25-A716-171F28552C33Q41779469-1C59D44B-8148-449B-9F24-3D65AC6D9F27Q44436988-3B3A0454-1AB9-48D7-9E98-A72C062AA552Q52881957-79DF6B3F-B3B5-4530-A859-F47D9DB7E7C3Q55509033-46FD51D4-2C05-49E1-ACE5-5BF9723B2E31
P2860
Low doses of cisplatin or gemcitabine plus Photofrin/photodynamic therapy: Disjointed cell cycle phase-related activity accounts for synergistic outcome in metastatic non-small cell lung cancer cells (H1299).
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Low doses of cisplatin or gemc ...... ell lung cancer cells (H1299).
@en
type
label
Low doses of cisplatin or gemc ...... ell lung cancer cells (H1299).
@en
prefLabel
Low doses of cisplatin or gemc ...... ell lung cancer cells (H1299).
@en
P2093
P50
P1476
Low doses of cisplatin or gemc ...... cell lung cancer cells (H1299)
@en
P2093
Angela Chiaviello
Elena Reddi
Gianfranco Canti
P304
P356
10.1158/1535-7163.MCT-05-0425
P577
2006-03-01T00:00:00Z